Epsilon-Aminocaproic Acid Inhibits the Activity of Factor VIII Inhibitors in Patients with Severe Haemophilia A in vivo and in vitro

Publisher： Karger

E-ISSN： 1421-9662|103|2|67-72

ISSN： 0001-5792

Source： Acta Haematologica, Vol.103, Iss.2, 2000-05, pp. : 67-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 10, Iss. 11, 2012-11 ,pp. : 2328-2337

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies

By  

CANCER, Vol. 119, Iss. 21, 2013-11 ,pp. : 3784-3787

John Wiley & Sons Inc

Access to resources Recommend Favorite

The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full‐length to B‐domain‐deleted factor VIII: a prospective cohort comparison

By  

HAEMOPHILIA, Vol. 21, Iss. 2, 2015-03 ,pp. : 219-226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Break‐through bleeding in relation to pharmacokinetics of Factor VIII in paediatric patients with severe haemophilia A

By  

HAEMOPHILIA, Vol. 24, Iss. 1, 2018-01 ,pp. : 120-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factor viii assays in haemophilia a patients treated with refacto™

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 121, Iss. 2, 2003-04 ,pp. : 379-380

John Wiley & Sons Inc

Access to resources Recommend Favorite